Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion type Assertion NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_head.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion description "[Compared with the drug-resistance group, the Ca2+ concentration in cells and the expression of LRP in lung cancer drug-resistance cells A549/DDP of the high-dose group, the low-dose group and the normal group of Chinese medicine were significantly different (all P<0.01), the LRP expression of the normal group was obviously higher than that of the drug-resistance group (P<0.05).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_provenance.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion evidence source_evidence_literature NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_provenance.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion SIO_000772 18219453 NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_provenance.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion wasDerivedFrom befree-20140225 NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_provenance.
- NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_assertion wasGeneratedBy ECO_0000203 NP804161.RAQ-P3LurRWkhK2-jmsBczKEu7h5NM95PH-OR6aEHje0M130_provenance.